Tag: immunohematology market analysis

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Immunohematology Market Forecast: What Value Will The Market Reach By 2030?

The immunohematology market has witnessed consistent expansion in recent years. It is projected to increase from $2.56 billion in 2025 to $2.69 billion in 2026, showing a compound annual growth rate (CAGR) of 4.9%. This growth in previous periods is attributable to the rising occurrence of blood disorders, an elevated demand for safe blood transfusions, the establishment of blood banks, the expansion of diagnostic laboratories, and progress in hematology reagents.

The immunohematology market is anticipated to show significant expansion in the coming years. It is projected to achieve a value of $3.27 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 5.0%. This forecasted growth can be attributed to several factors including technological progress in analyzers, the integration of AI into laboratory diagnostics, the rise of precision medicine, the adoption of digital health systems, and the broadening of blood screening initiatives. Noteworthy trends expected during this period involve advanced methods for blood typing, increased automation in immunohematology testing, personalized transfusion strategies, point-of-care immune diagnostic tools, and the integration of laboratory information systems.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=10295&type=smp&name=Immunohematology%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Immunohematology Market Opportunity Drivers: What’s Unlocking New Revenue Potential?

The immunohematology market is projected to experience growth driven by the aging population, which describes a demographic trend where the proportion of elderly individuals within a society increases. Immunohematology is crucial for managing age-related transfusion requirements, ensuring the safe use of blood products, and supporting medical interventions for this demographic. As an illustration, in January 2024, the US-based nonprofit organization Population Reference Bureau indicated that the number of Americans aged 65 and older is expected to climb from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Concurrently, this group’s share of the overall population is also foreseen to rise from 17% to 23% during the same period. Thus, the aging population is a primary force propelling the expansion of the immunohematology market.

Immunohematology Market Segment Breakdown: Which Categories Lead On Revenue?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

Immunohematology Market Innovation Trends Shaping Future Development

Companies active in the immunohematology market are focused on developing innovative diagnostic solutions, such as soluble recombinant proteins, designed to overcome interference from the cancer therapy daratumumab. A soluble recombinant protein is one produced through recombinant DNA technology that remains properly folded and functional in a soluble form within a host cell or solution, making it useful in research and therapeutic applications. For example, in November 2023, Grifols, S.A., a Spain-based pharmaceutical company, launched the Grifols sCD38 solution. Grifols’ sCD38 is the first-ever soluble recombinant protein, developed to address the interference caused by the cancer therapy daratumumab in vital blood transfusion compatibility testing. Specifically designed for multiple myeloma patients, this groundbreaking solution blocks daratumumab from attaching to CD38 proteins on red blood cells, ensuring precise pre-transfusion test outcomes. By facilitating a more efficient process for screening, identification, and crossmatching, Grifols sCD38 enhances blood transfusion protocols and minimizes delays in delivering lifesaving transfusions.

Immunohematology Market Leading Players And Competitive Positioning

Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

View The Full Immunohematology Market Report:

https://thebusinessresearchcompany.com/report/immunohematology-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Immunohematology Market Geographic Analysis: Where Is Demand Accelerating Fastest?

North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Immunohematology Market Size And Revenue Forecast Through 2030

The immunohematology market has experienced consistent growth over the past several years. From a valuation of $2.56 billion in 2025, it is projected to reach $2.69 billion by 2026, reflecting a compound annual growth rate (CAGR) of 4.9%. This historical expansion has been driven by factors such as the rising incidence of blood disorders, a growing need for secure blood transfusions, the establishment of more blood banks, an increase in the number of diagnostic laboratories, and ongoing improvements in hematology reagents.

The immunohematology sector is anticipated to experience significant expansion over the coming years. By 2030, its market value is projected to reach $3.27 billion, reflecting a compound annual growth rate (CAGR) of 5.0%. This upward trajectory in the forecast period is driven by factors such as progress in analyzer technology, the application of artificial intelligence within lab diagnostics, a growing focus on precision medicine, the incorporation of digital health platforms, and the widening reach of blood screening initiatives. Key developments shaping this period involve cutting-edge blood typing methods, increased automation in immunohematology procedures, customized approaches to transfusion therapy, immunological diagnostics performed at the point of care, and the seamless connection of laboratory information systems.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Immunohematology Market Growth Factors Supporting Long-Term Expansion

The growth of the immunohematology market is being significantly driven by the aging population in the coming years. This demographic trend, defined by a rising share of elderly individuals within a society, creates a high demand for blood-related medical care. Immunohematology plays a critical role in managing transfusion requirements specific to older adults, ensuring the safe administration of blood products and supporting various healthcare procedures for this group. To illustrate, data from January 2024 published by the Population Reference Bureau, a nonprofit organization based in the United States, indicates that the number of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Furthermore, this age cohort’s proportion of the total US population is forecasted to climb from 17% to 23% over that same interval. Consequently, the aging population is a key factor propelling the immunohematology market forward.

Immunohematology Market Segment Analysis: What Are The Major Market Categories?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

Immunohematology Market Industry Trends Shaping Future Revenue Growth

Key players in the immunohematology field are directing their efforts toward creating advanced diagnostic tools, including soluble recombinant proteins engineered to counteract the disruptive effects of the cancer drug daratumumab on testing. Such proteins are generated via recombinant DNA methods, preserving their correct structure and biological activity when dissolved in a host system or solution, which supports their utility in both research and medical contexts. As an example, in November 2023, Grifols, S.A., a pharmaceutical firm based in Spain, introduced its Grifols sCD38 product, marking the debut of a soluble recombinant protein in the market. This innovation was crafted to mitigate the obstacles presented by daratumumab in critical blood compatibility assessments for transfusions. Tailored specifically for individuals with multiple myeloma, the solution prevents daratumumab from binding to CD38 sites on red blood cells, thereby enabling accurate results in pre-transfusion evaluations. By streamlining the steps involved in screening, identification, and crossmatching, the Grifols sCD38 solution improves transfusion procedures and reduces delays in delivering essential blood products to patients.

Immunohematology Market Leading Companies Driving Competitive Growth

Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Access The Complete Immunohematology Market Report:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Immunohematology Market Leading Geography: Which Region Generates The Most Revenue?

North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Immunohematology Market Increase Between 2026 And 2030?

The immunohematology market has consistently expanded over recent years. This market is projected to expand from $2.56 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.9%. Historically, this growth has been fueled by factors such as the increasing prevalence of blood disorders, the growing demand for safe blood transfusions, the establishment of blood banks, the expansion of diagnostic laboratories, and innovations in hematology reagents.

The immunohematology market size is projected to experience substantial expansion over the coming years. It is anticipated to reach a valuation of $3.27 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.0%. This projected increase during the forecast period is largely driven by advancements in analyzer technology, the integration of artificial intelligence in lab diagnostics, the emergence of precision medicine, the incorporation of digital health systems, and the broadening scope of blood screening initiatives. Key developments expected in this period include sophisticated blood typing methods, increased automation in immunohematology assessments, tailored transfusion treatments, point-of-care immune diagnostic solutions, and the seamless integration of laboratory information systems.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

What Key Growth Drivers Are Influencing The Immunohematology Market?

The immunohematology market is expected to expand moving forward, driven by the aging population. This demographic situation is defined by a growing proportion of older individuals within a society or population. Immunohematology is crucial for addressing age-related transfusion requirements, ensuring the safe application of blood products, and supporting medical procedures for the elderly demographic. For example, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, reported that the population of Americans aged 65 and older is anticipated to climb from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Over the same period, this age group’s proportion of the overall population is also projected to increase from 17% to 23%. Therefore, the aging population is a significant factor propelling the growth of the immunohematology market.

What Are The Major Segment Categories Within The Immunohematology Market?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What Trends Are Influencing The Future Of The Immunohematology Market?

Key companies within the immunohematology market are dedicating efforts to developing innovative diagnostic solutions, such as soluble recombinant proteins designed to counteract the interference caused by the cancer therapy daratumumab. A soluble recombinant protein is one generated via recombinant DNA technology, which maintains its correct folding and functionality in a soluble form within a host cell or solution, thus aiding its use in both research and therapeutic applications. As an illustration, in November 2023, Grifols, S.A., a pharmaceutical company situated in Spain, introduced the Grifols sCD38 solution. Grifols’ sCD38 represents the first soluble recombinant protein ever, created to resolve the interference presented by the cancer treatment daratumumab in essential blood transfusion compatibility testing. This pioneering solution, specifically engineered for multiple myeloma patients, prevents daratumumab from binding to CD38 proteins on red blood cells, thereby ensuring accurate results for pre-transfusion tests. By facilitating a more efficient procedure for screening, identification, and crossmatching, Grifols sCD38 improves blood transfusion protocols and reduces delays in providing critical transfusions.

Which Companies Are Influencing The Immunohematology Market?

Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Access The Complete Immunohematology Market Report:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Is The Dominant Market In The Immunohematology Market?

North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Immunohematology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Browse Through More Reports Similar to the Global Immunohematology Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Immunodiagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Immunohematology Market From 2026 To 2030?

The immunohematology market size has shown steady growth in recent years. It is projected to increase from $2.56 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.9%. The market’s expansion in the past can be ascribed to several factors, including the increasing prevalence of blood disorders, a rising demand for safe blood transfusions, the development of blood banks, the growth in diagnostic laboratories, and advancements in hematology reagents.

The immunohematology market is projected to experience robust expansion over the coming years. It is set to reach a valuation of $3.27 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.0%. This anticipated growth during the forecast period is fueled by several factors, including advancements in analyzer technology, the integration of artificial intelligence into laboratory diagnostics, the increasing prevalence of precision medicine, the incorporation of digital health systems, and the broadening scope of blood screening initiatives. Key developments expected in this period encompass sophisticated blood typing methods, enhanced automation in immunohematology testing, tailored transfusion therapies, point-of-care immune diagnostic solutions, and the seamless integration of laboratory information systems.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Which Important Drivers Are Guiding The Immunohematology Market Growth?

The immunohematology market is anticipated to expand due to the increasing aging population in the future. This demographic trend signifies a rising percentage of older people in a society. Immunohematology plays a crucial role in meeting transfusion requirements for the elderly, guaranteeing the safe application of blood products, and aiding medical procedures for this demographic. For example, data from the US-based Population Reference Bureau in January 2024 indicates that the number of Americans aged 65 and above is projected to climb from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Their proportion within the total population is also forecasted to increase from 17% to 23% over the identical timeframe. Consequently, the aging population is a significant factor driving the expansion of the immunohematology market.

Which Segments Define The Immunohematology Market Segment Structure?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

Which Trends Are Shaping Growth In The Immunohematology Market?

Leading companies in the immunohematology market are concentrating on developing innovative diagnostic solutions, such as soluble recombinant proteins designed to counteract the interference caused by the cancer therapy daratumumab. A soluble recombinant protein is one produced through recombinant DNA technology that maintains its proper folding and function in a soluble state within a host cell or solution, thereby facilitating its application in research and therapeutic fields. For instance, in November 2023, Grifols, S.A., a pharmaceutical company based in Spain, launched the Grifols sCD38 solution. Grifols’ sCD38 is the first soluble recombinant protein ever created. It was developed to address the interference from the cancer therapy daratumumab in critical blood transfusion compatibility testing. Specifically created for multiple myeloma patients, this innovative solution prevents daratumumab from attaching to CD38 proteins on red blood cells, ensuring precise outcomes for pre-transfusion tests. By facilitating a more efficient process for screening, identification, and crossmatching, Grifols sCD38 enhances blood transfusion protocols and reduces delays in providing lifesaving transfusions.

Who Are The Established Players Within The Immunohematology Market?

Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Get The Full Immunohematology Market Report:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Dominates The Immunohematology Market By Market Share?

North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Immunohematology Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Browse Through More Reports Similar to the Global Immunohematology Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Immunodiagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Immunohematology Market By 2030 Starting From Its 2026 Size?

The immunohematology market size has observed consistent expansion over recent years. It is projected to expand from $2.56 billion in 2025 to $2.69 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 4.9%. The market’s growth in previous periods can be attributed to the increasing prevalence of blood disorders, a rising demand for safe blood transfusions, the development of blood banks, the growth in diagnostic laboratories, and advancements in hematology reagents.

The immunohematology market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a value of $3.27 billion, exhibiting a compound annual growth rate (CAGR) of 5.0%. This projected growth during the forecast period is attributable to several factors, including ongoing technological progress in analyzers, the increasing adoption of artificial intelligence in laboratory diagnostics, the growing prominence of precision medicine, the incorporation of digital health systems, and the broadening reach of blood screening initiatives. Key trends expected within the forecast timeframe encompass sophisticated blood typing methods, enhanced automation in immunohematology tests, individualized transfusion treatment, on-site immune diagnostic tools, and the seamless integration of laboratory information systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Immunohematology Market?

The expanding elderly demographic is set to fuel the expansion of the immunohematology market moving forward. An aging population is defined as a demographic scenario where the proportion of older individuals within a society or population increases. Immunohematology plays a vital role in addressing transfusion requirements linked to age, guaranteeing the safe application of blood products, and supporting medical procedures for the elderly. For example, as reported in January 2024 by the Population Reference Bureau, a US-based nonprofit organization, the number of Americans aged 65 and older is projected to rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Furthermore, this age group’s percentage of the total population is expected to climb from 17% to 23% during the same timeframe. Consequently, the aging population is a significant factor driving the growth of the immunohematology market.

Which Segment Categories Define The Immunohematology Market?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What Major Market Trends Are Driving Changes In The Immunohematology Market?

Major companies in the immunohematology market are concentrating on developing advanced diagnostic methods, such as soluble recombinant proteins, designed to counteract the interference caused by the cancer therapy daratumumab. A soluble recombinant protein is a protein created using recombinant DNA technology that remains correctly folded and functional in a soluble form within a host cell or solution, thus facilitating its application in research and therapeutic contexts. For example, in November 2023, Grifols, S.A., a Spanish pharmaceutical company, introduced its Grifols sCD38 solution. Grifols sCD38 is the first-ever soluble recombinant protein developed to address the interference from the cancer therapy daratumumab in vital blood transfusion compatibility testing. Specifically formulated for multiple myeloma patients, this innovative solution prevents daratumumab from attaching to CD38 proteins on red blood cells, thereby ensuring precise pre-transfusion test results. By streamlining the processes for screening, identification, and crossmatching, Grifols sCD38 enhances blood transfusion protocols and minimizes delays in delivering essential transfusions.

Who Are The Top Companies Competing In The Immunohematology Market?

Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Read the full immunohematology market report here:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Regions Are Projected To Dominate The Immunohematology Market In The Coming Years?

North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Immunohematology Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

Browse Through More Reports Similar to the Global Immunohematology Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Immunodiagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the immunohematology market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Immunohematology Market reach by 2030 starting from 2026 levels?

The immunohematology market has experienced consistent growth in recent years. It is expected to expand from $2.56 billion in 2025 to $2.69 billion by 2026, registering a compound annual growth rate (CAGR) of 4.9%. This expansion in the past can be linked to factors such as the increasing prevalence of blood disorders, a heightened demand for safe blood transfusions, the establishment of blood banks, the proliferation of diagnostic laboratories, and progress in hematology reagents.

The immunohematology market is anticipated to experience substantial expansion over the upcoming years. Its valuation is projected to reach $3.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. This projected growth during the forecast timeframe stems from several factors, including ongoing technological improvements in analyzers, the increasing adoption of AI in laboratory diagnostics, the emergence of precision medicine, the integration of digital health systems, and the broadening of blood screening initiatives. Key developments expected within this period involve advanced blood typing methods, enhanced automation in immunohematology testing, customized transfusion therapies, point-of-care immune diagnostic solutions, and the seamless integration of laboratory information systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Which Drivers Are Influencing Long-Term Growth In The Immunohematology Market?

The immunohematology market is expected to experience growth primarily driven by the aging population. An aging population is a demographic phenomenon characterized by an increasing percentage of older individuals within a society. Immunohematology is crucial for addressing transfusion needs specific to older individuals, guaranteeing the safe application of blood products, and supporting various medical interventions required by this demographic. For instance, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, indicated that the population of Americans aged 65 and older is projected to rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. During this same timeframe, this age group’s share of the overall population is also anticipated to climb from 17% to 23%. Therefore, the aging population serves as a significant catalyst for the expansion of the immunohematology market.

How Is The Immunohematology Market Divided Into Segments?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

How Are Emerging Trends Affecting The Progression Of The Immunohematology Market?

Leading firms within the immunohematology sector are concentrating on developing advanced diagnostic offerings, notably soluble recombinant proteins crafted to counteract the interference caused by the cancer therapy daratumumab. A soluble recombinant protein is a protein produced using recombinant DNA technology that sustains proper folding and functionality in a soluble state within a host cell or solution, thereby facilitating its application in research and medical treatments. For instance, in November 2023, Grifols, S.A., a pharmaceutical company based in Spain, launched its Grifols sCD38 solution. Grifols’ sCD38 stands as the pioneering soluble recombinant protein. It was created to address the interference daratumumab cancer therapy generates in essential blood transfusion compatibility tests. Specifically designed for individuals with multiple myeloma, this groundbreaking solution inhibits daratumumab from attaching to CD38 proteins on red blood cells, ensuring precise outcomes for pre-transfusion testing. By enabling a more efficient process for screening, identification, and crossmatching, Grifols sCD38 enhances blood transfusion protocols and minimizes delays in the delivery of life-saving transfusions.

Which Major Firms Are Strengthening Their Position In The Immunohematology Market?

Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Immunohematology Market?

North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Immunohematology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

Browse Through More Reports Similar to the Global Immunohematology Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Immunodiagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the immunohematology market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Immunohematology Market Be Worth By 2029, And What CAGR Will It Achieve?

The immunohematology market has experienced steady growth in recent years. It is anticipated to expand from $2.46 billion in 2024 to $2.55 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.6%. The market’s historical growth can be attributed to improvements in blood transfusion science, the widespread occurrence of blood disorders, the expansion of blood banks, government-led blood safety initiatives, an increase in surgical operations, and greater awareness of risks related to transfusions.

The immunohematology market is projected to demonstrate significant expansion over the next few years. It is forecast to reach $3.17 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.7%. This growth during the forecast period is primarily driven by factors such as the increasing requirement for point-of-care testing, the introduction of novel blood products, the expansion of healthcare infrastructure, the use of genetic testing for blood compatibility, and regulatory frameworks supporting blood safety. Noteworthy trends anticipated in the forecast period include the adoption of automation and high-throughput systems, advancements in molecular blood typing methods, enhanced antibody detection techniques, the implementation of patient blood management programs, the integration of AI in analysis, and the broader incorporation of telemedicine.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Which Factors Are Driving The Immunohematology Market Forward?

The increasing prevalence of hematological disorders is anticipated to propel the expansion of the immunohematology market in the coming years. Hematological disorders represent a diverse range of conditions impacting the blood and its various components, such as red blood cells, white blood cells, platelets, and plasma. Immunohematology is vital for ensuring safe and effective blood transfusions by helping to prevent adverse reactions caused by incompatible blood types or the presence of antibodies in the recipient’s blood. Furthermore, immunohematology techniques are utilized for the diagnosis and treatment of immune system-related diseases that may affect the hematological system. For instance, according to Cancer Research UK, a UK-based research organization, the average number of new leukemia cases caused by hematological disorders in the UK is expected to climb from roughly 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Therefore, the rising prevalence rate of hematological disorders is driving the growth of the immunohematology market.

Which Segments Form The Key Structure Of The Immunohematology Market?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What Strategic Shifts And Innovations Are Influencing The Immunohematology Market?

Leading companies in the immunohematology market are prioritizing the creation of advanced diagnostic solutions, such as soluble recombinant proteins, designed to counteract the interference of the cancer therapy daratumumab. A soluble recombinant protein is one created using recombinant DNA technology that maintains its correct folding and function in a soluble state within a host cell or solution, making it suitable for research and therapeutic uses. As an illustration, in November 2023, Grifols, S.A., a Spain-based pharmaceutical company, launched its Grifols sCD38 solution. Grifols’ sCD38 is the pioneering soluble recombinant protein, specifically developed to address interference from the cancer therapy daratumumab during crucial blood transfusion compatibility testing. This innovative solution, tailored for multiple myeloma patients, works by preventing daratumumab from attaching to CD38 proteins on red blood cells, thereby ensuring accurate pre-transfusion test outcomes. By streamlining screening, identification, and crossmatching procedures, Grifols sCD38 enhances blood transfusion protocols and significantly reduces delays in delivering vital transfusions.

Which Firms Are Making The Biggest Impact In The Immunohematology Market?

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Is Expected To Lead The Immunohematology Market In The Next Few Years?

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

Browse Through More Reports Similar to the Global Immunohematology Market 2025, By The Business Research Company

Out Of Home Advertising Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/out-of-home-advertising-global-market-report

Print Advertising Distribution Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/print-advertising-distribution-global-market-report

Print Advertising Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/print-advertising-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Immunohematology Market Expected To Expand Between 2025 And 2029?

The immunohematology market has shown consistent expansion over recent years. It is anticipated to increase from $2.46 billion in 2024 to $2.55 billion in 2025, progressing at a compound annual growth rate (CAGR) of 3.6%. This historical development can be ascribed to progress in blood transfusion science, the common occurrence of blood disorders, the growth of blood banks, governmental initiatives for ensuring blood safety, a rise in surgical procedures, and greater understanding of risks tied to transfusions.

The immunohematology market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $3.17 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.7%. This growth during the projection period stems from factors such as a rising need for point-of-care diagnostics, the introduction of new blood products, advancements in healthcare facilities, genetic assessments for blood matching, and governmental backing for ensuring blood safety. Key developments expected in the forecast timeframe encompass automation coupled with high-throughput capabilities, molecular techniques for blood typing, advancements in antibody identification, comprehensive patient blood management initiatives, the incorporation of AI into analytical processes, and the widespread adoption of telemedicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Which Drivers Are Impacting The Immunohematology Market?

The rising occurrence of hematological disorders is anticipated to spur the growth of the immunohematology market. Hematological disorders are a broad category of conditions that affect the blood, including its vital components such as red blood cells, white blood cells, platelets, and plasma. Immunohematology is crucial for safe and efficient blood transfusions, preventing reactions caused by incompatible blood types or the presence of antibodies in the recipient. Additionally, immunohematology techniques are utilized to diagnose and manage diseases of the immune system that may impact the hematological system. For instance, data from Cancer Research UK, a UK-based research organization, indicates that the average annual number of new leukemia cases attributed to hematological disorders in the UK is projected to rise from approximately 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Thus, the increasing incidence of hematological disorders is a key driver for the expansion of the immunohematology market.

What Are The Major Segments Identified In The Immunohematology Market?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What Are The Latest Industry Trends Transforming The Immunohematology Market?

Leading companies in the immunohematology market are concentrating on creating advanced diagnostic solutions, which include soluble recombinant proteins aimed at counteracting the interference from the cancer therapy daratumumab. A soluble recombinant protein is one generated via recombinant DNA technology that maintains its proper folding and function in a soluble state within a host cell or solution, thereby simplifying its application in research and therapeutic contexts. For instance, in November 2023, Grifols, S.A., a pharmaceutical firm based in Spain, launched the Grifols sCD38 solution. Grifols’ sCD38 stands as the inaugural soluble recombinant protein, developed to address the interference caused by the cancer therapy daratumumab during essential blood transfusion compatibility testing. This innovative solution, specifically designed for multiple myeloma patients, prevents daratumumab from attaching to CD38 proteins on red blood cells, thus ensuring precise pre-transfusion test outcomes. By enabling a more streamlined process for screening, identification, and crossmatching, Grifols sCD38 improves blood transfusion protocols and minimizes delays in delivering lifesaving transfusions.

Which Key Players Are Driving Competition In The Immunohematology Market?

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Currently Holds The Largest Share Of The Immunohematology Market?

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Immunohematology Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

Browse Through More Reports Similar to the Global Immunohematology Market 2025, By The Business Research Company

Out Of Home Advertising Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/out-of-home-advertising-global-market-report

Print Advertising Distribution Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/print-advertising-distribution-global-market-report

Print Advertising Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/print-advertising-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model